What the six lenses say about AJANTPHARM — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How AJANTPHARM’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +1.9pp | -1.2pp | +4.7pp | +15.5pp | +20.2pp | +39.6pp |
Nifty 500 Broad-market baseline | +1.8pp | -1.2pp | +3.7pp | +13.9pp | +14.4pp | +34.4pp |
Sector Own-sector index | — | — | +0.8pp | +7.9pp | +1.3pp | +13.6pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
AJANTPHARM daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
AJANTPHARM ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,145 | 1,187 | 1,146 | 1,170 | 1,303 | 1,354 | 1,375 | 1,422 |
| ↳ change QoQ | — | +3.6% | -3.4% | +2.1% | +11.4% | +3.9% | +1.6% | +3.4% |
| EBITDA (₹cr) | 357 | 331 | 351 | 297 | 351 | 328 | 382 | 333 |
| EBITDA margin | 31.2% | 27.9% | 30.6% | 25.4% | 26.9% | 24.2% | 27.8% | 23.4% |
| PAT (₹cr) | 246 | 216 | 233 | 225 | 255 | 260 | 274 | 267 |
| ↳ change QoQ | — | -11.9% | +7.6% | -3.4% | +13.3% | +2.0% | +5.4% | -2.6% |
| Net margin | 21.5% | 18.2% | 20.3% | 19.2% | 19.6% | 19.2% | 19.9% | 18.8% |
| EPS (₹) | 19.54 | 17.27 | 18.60 | 18.03 | 20.44 | 20.83 | 21.91 | 21.35 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A dividend declaration — a cash return to shareholders.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding AJANTPHARM (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Nippon India Small Cap Dir Bns | 0.73% | 78,957 | |
| Nippon India Small Cap Gr | 0.73% | 78,957 | |
| Nippon India Small Cap Gr Bns | 0.73% | 78,957 | |
| Kotak Flexicap Reg Gr | 1.00% | 56,119 | |
| Kotak Large & Midcap Reg Gr | 1.07% | 32,050 | |
| HDFC Large and Mid Cap Gr | 1.03% | 30,099 | |
| Canara Robeco Large & Mid Cap Reg Gr | 0.55% | 26,062 | |
| UTI Flexi Cap Reg Gr | 1.92% | 24,036 | |
| SBI Flexicap Reg Gr | 0.65% | 22,897 | |
| HDFC Multi Cap Reg Gr | 0.59% | 20,583 |
ETFs holding AJANTPHARM (6)